Clínica Baviera, S.A. (FRA:D9Z)
Germany
· Delayed Price · Currency is EUR 47.80
+0.90 (1.92%)
At close: Dec 5, 2025
Clínica Baviera Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 761 | 499 | 375 | 284 | 346 | 230 | Upgrade
|
| Market Cap Growth | 42.02% | 33.02% | 31.81% | -17.69% | 50.35% | -1.40% | Upgrade
|
| Enterprise Value | 784 | 529 | 376 | 286 | 360 | 264 | Upgrade
|
| Last Close Price | 47.80 | 29.98 | 21.24 | 15.33 | 17.80 | 11.15 | Upgrade
|
| PE Ratio | 18.79 | 12.41 | 10.42 | 9.64 | 12.62 | 16.49 | Upgrade
|
| PS Ratio | 2.56 | 1.88 | 1.65 | 1.43 | 2.00 | 1.88 | Upgrade
|
| PB Ratio | 7.81 | 5.07 | 4.06 | 4.16 | 6.24 | 5.12 | Upgrade
|
| P/TBV Ratio | 13.20 | 8.33 | 5.09 | 5.44 | 8.86 | 7.84 | Upgrade
|
| P/FCF Ratio | 16.39 | 13.86 | 10.67 | 7.23 | 9.53 | 9.73 | Upgrade
|
| P/OCF Ratio | 10.55 | 7.98 | 6.49 | 5.33 | 7.38 | 7.31 | Upgrade
|
| EV/Sales Ratio | 2.64 | 1.99 | 1.66 | 1.44 | 2.08 | 2.15 | Upgrade
|
| EV/EBITDA Ratio | 9.58 | 7.00 | 5.66 | 5.04 | 6.75 | 7.96 | Upgrade
|
| EV/EBIT Ratio | 13.22 | 9.51 | 7.52 | 6.82 | 9.13 | 13.33 | Upgrade
|
| EV/FCF Ratio | 16.90 | 14.70 | 10.71 | 7.27 | 9.93 | 11.18 | Upgrade
|
| Debt / Equity Ratio | 0.68 | 0.62 | 0.51 | 0.70 | 0.93 | 1.22 | Upgrade
|
| Debt / EBITDA Ratio | 0.81 | 0.81 | 0.71 | 0.84 | 0.96 | 1.65 | Upgrade
|
| Debt / FCF Ratio | 1.44 | 1.70 | 1.35 | 1.21 | 1.42 | 2.31 | Upgrade
|
| Asset Turnover | 1.38 | 1.36 | 1.38 | 1.40 | 1.36 | 1.10 | Upgrade
|
| Inventory Turnover | - | 46.27 | 49.67 | 47.16 | 47.03 | 45.24 | Upgrade
|
| Quick Ratio | 0.98 | 0.84 | 1.18 | 1.01 | 1.00 | 0.91 | Upgrade
|
| Current Ratio | 0.98 | 0.95 | 1.28 | 1.09 | 1.06 | 0.97 | Upgrade
|
| Return on Equity (ROE) | 45.39% | 43.16% | 45.73% | 48.72% | 55.70% | 37.33% | Upgrade
|
| Return on Assets (ROA) | 17.21% | 17.82% | 19.03% | 18.47% | 19.36% | 11.14% | Upgrade
|
| Return on Capital (ROIC) | 23.87% | 23.24% | 24.46% | 23.53% | 23.90% | 13.48% | Upgrade
|
| Return on Capital Employed (ROCE) | 34.10% | 34.50% | 37.50% | 38.50% | 40.30% | 22.40% | Upgrade
|
| Earnings Yield | 5.32% | 8.06% | 9.59% | 10.38% | 7.92% | 6.07% | Upgrade
|
| FCF Yield | 6.10% | 7.22% | 9.37% | 13.83% | 10.50% | 10.28% | Upgrade
|
| Dividend Yield | 2.66% | 5.24% | 7.39% | 8.48% | 5.79% | 4.95% | Upgrade
|
| Payout Ratio | 63.13% | 62.39% | 36.26% | 56.89% | 62.62% | - | Upgrade
|
| Buyback Yield / Dilution | -0.16% | 1.85% | - | - | -0.01% | 0.01% | Upgrade
|
| Total Shareholder Return | 2.50% | 7.09% | 7.39% | 8.48% | 5.77% | 4.96% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.